myo-Inositol metabolism in the neonatal and developing rat fed a myo-inositol-free diet

Area of Science:

• Biochemistry
• Developmental Biology
• Nutritional Science

Background:

• Myo-inositol is essential for cell membrane synthesis and signaling pathways.
• Dietary myo-inositol restriction in early life may impact growth and neurological development.
• Understanding the effects of myo-inositol deficiency is crucial for infant nutrition and metabolic health.

Purpose of the Study:

• To investigate the effects of myo-inositol restriction on neonatal rat growth, tissue myo-inositol levels, and neurological development.
• To assess the potential for fatty liver development in myo-inositol deficient rats.
• To evaluate myelination and mitochondriogenesis in the brains of myo-inositol deprived rats.

Main Methods:

• Neonatal Holtzman rats were fed a myo-inositol restricted liquid formula and diet from 6 to 72 days of age.
• Weight gain was monitored throughout the study.
• Free and lipid-bound myo-inositol levels were measured in various tissues.
• Enzyme activities (2',3'-cyclic nucleotide-3'-phosphohydrolase and fumarase) were assessed to evaluate myelination and mitochondriogenesis.

Main Results:

• No significant differences in weight gain were observed between control and myo-inositol restricted groups.
• Most tissues exhibited lower free myo-inositol levels in restricted rats, except for the liver.
• Despite reduced myo-inositol in the liver, no fatty liver was observed.
• Cerebrum and cerebellum showed normal myelination and mitochondriogenesis, respectively.

Conclusions:

• Neonatal myo-inositol restriction does not impede overall growth or cause fatty liver in rats.
• Key neurological functions like myelination and mitochondriogenesis are maintained despite reduced myo-inositol levels in the brain.
• The liver may have a compensatory mechanism to maintain myo-inositol homeostasis.